PubMed
Growth hormone-releasing peptide-6 stimulates GH, ACTH, and cortisol release
Arvat E, Maccario M, Di Vito L, et al. J Clin Endocrinol Metab. 1998
Compare
Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.
Last reviewed . By the PeptIQ team.
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 64% · Mixed 24% · Unfavorable overall 12%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 100–200 mcg · Most common: 100–200 mcg
Reports span 25–600 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 59% said they felt similar to their last entry, 38% more positive, and 14% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 33 days · Based on 273 repeat reporters
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 67% · Mixed 24% · Unfavorable overall 9%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 200–400 mcg · Most common: 200–400 mcg
Reports span 25–1000 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 62% said they felt similar to their last entry, 41% more positive, and 17% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 24 days · Based on 29 repeat reporters
Published sources linked on the GHRP-6 and SNAP-8 wiki pages.
PubMed
Arvat E, Maccario M, Di Vito L, et al. J Clin Endocrinol Metab. 1998
PubMed
Ghigo E, Arvat E, Camanni F. Endocrine. 2008
PubMed
Raikou V, Varvaresou A, Panderi I, et al. J Cosmet Dermatol. 2009
PubMed
Solá P, Mereu E, Bonjoch J, et al. Nature aging. 2023
PubMed
Shook BA, Wasko RR, Rivera-Gonzalez GC, et al. Science (New York, N.Y.). 2018